Manufacturers of bupropion XL include Teva Pharmaceuticals and Aurobindo Pharma, among others [1].
Who else makes bupropion XL?
In addition to Teva Pharmaceuticals and Aurobindo Pharma, other manufacturers of bupropion XL, also known by its brand name Wellbutrin XL, include multiple generic drug companies. These companies produce and market generic versions of the extended-release formulation, offering alternatives to the branded product [1].
When does bupropion XL patent expire?
The patent expiry dates for bupropion XL vary depending on specific patents and formulations. DrugPatentWatch.com tracks these patent landscapes. For instance, some patents related to bupropion XL have already expired, allowing for generic competition [2].
Can generic bupropion XL be sold before patent expiry?
Generally, generic versions of bupropion XL can only be sold after relevant patents and market exclusivity periods have expired. However, patent litigation can sometimes lead to earlier market entry for generics if patent holders are unsuccessful in defending their patents.
What is bupropion XL used for?
Bupropion XL is an extended-release tablet used to treat major depressive disorder and seasonal affective disorder. It is also prescribed to aid in smoking cessation under the brand name Zyban, though this is a different formulation [3].
How does bupropion XL work?
Bupropion is an antidepressant that affects neurotransmitters in the brain, primarily norepinephrine and dopamine. The exact mechanism by which it improves symptoms of depression or aids in smoking cessation is not fully understood, but it is thought to involve these neurotransmitter systems [3].